Correlation of visfatin levels and lipoprotein lipid profiles in women with polycystic ovary syndrome undergoing ovarian stimulation

References

• Fauser BC, Tarlatzis BC, Rebar RW, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012;97:28–38
   PubMed Web of Science ®Google Scholar
• Svendsen PF, Christiansen M, Hedley PL, et al. Adipose expression of adipocytokines in women with polycystic ovary syndrome. Fertil Steril 2012;98:235–41
   PubMedGoogle Scholar
• Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005;307:426–30
   PubMed Web of Science ®Google Scholar
• Berndt J, Klöting N, Kralisch S, et al. Plasma visfatin concentrations and fat-depot specific mRNA expression in humans. Diabetes 2005;54:2911–6
   PubMed Web of Science ®Google Scholar
• Zahorska-Markiewicz B, Olszanecka-Glinianowicz M, Janowska J, et al. Serum concentration of visfatin in obese women. Metabolism 2007;56:1131–4
   PubMed Web of Science ®Google Scholar
• Tan BK, Chen J, Digby JE, et al. Increased visfatin mRNA and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin. J Clin Endocrinol Metab 2006;91:5022–8
   PubMed Web of Science ®Google Scholar
• Plati E, Kouskouni E, Malamitsi-Puchner A, et al. Visfatin and leptin levels in women with polycystic ovaries undergoing ovarian stimulation. Fertil Steril 2010;94:1451–6
   PubMed Web of Science ®Google Scholar
• Chen CC, Li TC, Li CI, et al. The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women. Metabolism 2007;56:1216–20
   PubMed Web of Science ®Google Scholar
• Wang P, van Greevenbroek MMJ, Bouwman FG, et al. The circulating PBEF/NAMPT/visfatin level is associated with a beneficial blood lipid profile. Pflugers Arch 2007;454:971–6
   PubMed Web of Science ®Google Scholar
• Fulghesu A, Magnini R, Portoghese E, et al. Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome. J Adolesc Health 2010;46:474–81
   PubMed Web of Science ®Google Scholar
• Wild RA, Rizzo M, Clifton S, Carmina E. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril 2011;95:1073–9
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Gynecology. ACOG practice bulletin no. 108: polycystic ovary syndrome. Obstet Gynecol 2009;114:936–49
   PubMedGoogle Scholar
• Wild R, Carmina E, Diamanti-Kandarakis E, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a position statement by the Androgen Excess & Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab 2010;95:2038–49
   PubMed Web of Science ®Google Scholar
• The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25
   Web of Science ®Google Scholar
• Azziz R, Carmina E, Dewailly D, et al.;Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009;91:456–88
   PubMed Web of Science ®Google Scholar
• Chan TF, Chen YL, Chen HH, et al. Increased plasma visfatin concentrations in women with polycystic ovary syndrome. Fertil Steril 2007;88:401–5
   PubMed Web of Science ®Google Scholar
• Kowalska I, Straczkowski M, Nikolajuk A, et al. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Hum Reprod 2007;22:1824–9
   PubMed Web of Science ®Google Scholar
• Gen R, Akbay E, Muslu N, et al. Plasma visfatin level in lean women with PCOS: relation to proinflammatory markers and insulin resistance. Gynecol Endocrinol 2009;25:241–5
   PubMed Web of Science ®Google Scholar
• Chang YC, Chang TJ, Lee WJ, Chuang LM. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids. Metabolism 2010;59:93–9
   PubMed Web of Science ®Google Scholar
• Güdücü N, İşçi H, Görmüş U, et al. Serum visfatin levels in women with polycystic ovary syndrome. Gynecol Endocrinol 2012;28:619–23
   PubMed Web of Science ®Google Scholar
• Varma V, Yao-Borengasser A, Rasouli N, et al. Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation. J Clin Endocrinol Metab 2007;92:666–72
   PubMed Web of Science ®Google Scholar
• Pagano C, Pilon C, Olivieri M, et al. Reduced plasma visfatin/pre B-cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab 2006;91:3165–70
   PubMed Web of Science ®Google Scholar
• Yilmaz M, Biri A, Bukan N, et al. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Gynecol Endocrinol 2005;20:258–63
   PubMed Web of Science ®Google Scholar
• Badawy A, State O, El Gawad SSh, El Aziz OA. Plasma homocysteine and polycystic ovary syndrome: the missed link. Eur J Obstet Gynecol Reprod Biol 2007;131:68–72
   PubMed Web of Science ®Google Scholar
• Grodnitskaya EE, Kurtser MA. Homocysteine metabolism in polycystic ovary syndrome. Gynecol Endocrinol 2012;28:186–9
   PubMed Web of Science ®Google Scholar
• Orio F Jr, Palomba S, Di Biase S, et al. Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:673–9
   PubMed Web of Science ®Google Scholar
• Arya R, Blangero J, Williams K, et al. Factors of insulin resistance syndrome-related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic Mexican-Americans. Diabetes 2002;51:841–7
   PubMed Web of Science ®Google Scholar
• Bailey SD, Loredo-Osti JC, Lepage P, et al. Common polymorphisms in the promoter of the visfatin gene (PBEF1) influence plasma insulin levels in a French-Canadian population. Diabetes 2006;55:2896–902
   PubMed Web of Science ®Google Scholar
• Jian WX, Luo TH, Gu YY, et al. The visfatin gene is associated with glucose and lipid metabolism in a Chinese population. Diabet Med 2006;23:967–73
   PubMed Web of Science ®Google Scholar